These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38687941)

  • 21. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
    Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
    Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
    Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
    Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
    Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
    Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
    Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
    J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-cancer effect and the underlying mechanisms of gypenosides on human colorectal cancer SW-480 cells.
    Yan H; Wang X; Niu J; Wang Y; Wang P; Liu Q
    PLoS One; 2014; 9(4):e95609. PubMed ID: 24752286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma.
    Wang Z; Wang YS; Chang ZM; Li L; Zhang Y; Lu MM; Zheng X; Li M; Shao D; Li J; Chen L; Dong WF
    Chem Biol Drug Des; 2017 Mar; 89(3):464-469. PubMed ID: 27618577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence.
    Ma J; Hu X; Liao C; Xiao H; Zhu Q; Li Y; Liu Z; Tao A; He Z; Xu C; Zheng K
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30889805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
    Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DPP-Cu
    Chen W; Ma M; Lai Q; Zhang Y; Liu Z
    Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy.
    Sun JG; Jiang Q; Zhang XP; Shan K; Liu BH; Zhao C; Yan B
    Int J Nanomedicine; 2019; 14():1489-1501. PubMed ID: 30880960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Magnetic Drug Delivery System with "OFF-ON" State via Specific Molecular Recognition and Conformational Changes for Precise Tumor Therapy.
    Liu J; Liu W; Zhang K; Shi J; Zhang Z
    Adv Healthc Mater; 2020 Feb; 9(3):e1901316. PubMed ID: 31858730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
    Liu Z; Tao Z; Zhang Q; Wan S; Zhang F; Zhang Y; Wu G; Wang J
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):687-695. PubMed ID: 29392452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma.
    Babaei M; Abnous K; Taghdisi SM; Amel Farzad S; Peivandi MT; Ramezani M; Alibolandi M
    Nanomedicine (Lond); 2017 Jun; 12(11):1261-1279. PubMed ID: 28520529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.